Pharmaceutical Development

Jacob Albrecht discusses the challenging but enjoyable road to manufacturing new medicines, and the creative aspects of process engineering.

Process engineers are bringing improved manufacturing to the pharmaceuticals industry. Read one process engineer's take on her work in the industry.

Suddenly, synthetic biology is being discussed a lot beyond the walls of academia and the pages of scientific journals. Today, it abounds in the mainstream press.

The market for chimeric antigen receptor (CAR) T-cell therapy is projected to be valued at almost $300 million by the end of 2018, and this number is expected to grow annually by 32% for the next decade.

A look at the future of chemical engineering from the perspective of pharmaceutical manufacturing.

Humans have roughly 40 trillion bacterial cells in their bodies; up to 1,000 species of bacteria live in the human gut alone.

Microorganisms have long been used to help humans carry out various processes such as brewing and the production of antibiotics, but these processes remain very complex, with bioreactors seen as “b

A new report released by the European Centre for Disease Prevention and control (ECDC) emphasizes that antimicrobial resistance remains one of the greatest public health threats today.

An international team of researchers has created new antiviral nanoparticles that show potential for outperforming current antiviral drugs.

New imagine of a key protein's signaling mechanism provides insights for better pharmaceuticals.

A new technique labels gene segments to help understand how the virus enters a cell and establishes co-infections.

The failure rate for new drugs and therapies under development exceeds 95%.

A compound found in a snail's venom yields pain-fighting effects in testing, presenting a possible opioid alternative.

Using nanostraws, scientists can now sample cell contents without disrupting a cell's natural processes.

As we approach ICBE 2017, which begins this weekend in San Diego, we look back at some of the exciting research that figured among 2016's highlights and look forward to the new developments to be unveiled at ICBE 2017.

Researchers at the University of California, Riverside, recently published work that suggests that the usefulness of studying pro- and anti-apoptotic proteins in a search for cancer

The 2016 D.I.C.

Tests by researchers at Baylor College of Medicine have recently shown that nanoparticles modified with polyethylene glycol selectively affect specific areas of the immune system, showing potential

It sounds like something straight out of a science fiction movie: bacteria that feeds on human flesh.

The U.S. government announced this week that it is putting aside $55 million to create a public database with health information on about one million volunteers.

AccBio 2015 is a four-day conference focusing on scientific, technical, business and regulatory advances in the field of biopharmaceutical development.